We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Pegylated Interferon - α2b With SARSCoV- 2 (COVID-19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04480138
Recruitment Status : Terminated (Due to non availability of eligible subjects and slow recruitment)
First Posted : July 21, 2020
Last Update Posted : July 12, 2022
Information provided by (Responsible Party):
Cadila Healthcare Limited

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 21, 2021
Actual Study Completion Date : June 21, 2021